NCT05160922 2026-03-30
Crizotinib Continuation Clinical Study
Pfizer
Phase 4 Active not recruiting
Pfizer
Princess Maxima Center for Pediatric Oncology
Turning Point Therapeutics, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Novartis